GEN Exclusives

More »

The Lists

More »
Aug 5, 2013

What the Top 15 Biopharma CEOs Are Making

Who are the highest-paid executives this year?

What the Top 15 Biopharma CEOs Are Making

The CEOs from Roche and Sanofi joined Novartis in raising the presence of non-U.S. companies on the list this year. [© Tijana - Fotolia.com]

  • #8. Joseph Jimenez

    Company: Novartis

    Full title: CEO

    2012 Compensation: $14,196,551 (CHF: 13,228,188)1

    2011 Compensation: $16,874,192 (CHF: 15,722,386)1

    % Change: -15.9%

    Position on 2012 List: #6

  • #7. John C. Lechleiter, Ph.D.

    Company: Eli Lilly

    Full title: Chairman of the Board, President, and CEO

    2012 Compensation: $14,620,633

    2011 Compensation: $16,370,094

    % Change: -10.7%

    Position on 2012 List: #5

  • #6. John C. Martin

    Company: Gilead Sciences

    Full title: Chairman of the Board and CEO

    2012 Compensation: $15,257,272

    2011 Compensation: $15,615,645

    % Change: -2.3%

    Position on 2012 List: #7

  • #5. Kenneth C. Frazier

    Company: Merck & Co.

    Full title: Chairman of the Board, President, and CEO

    2012 Compensation: $15,459,607

    2011 Compensation: $13,347,652

    % Change: 15.8%

    Position on 2012 List: #10

  • #4. Lamberto Andreotti

    Company: Bristol-Myers Squibb

    Full title: CEO

    2012 Compensation: $17,201,980

    2011 Compensation: $14,911,947

    % Change: 15.4%

    Position on 2012 List: #8

  • #3. Ian Read

    Company: Pfizer

    Full title: Chairman of the Board and CEO

    2012 Compensation: $25,634,136

    2011 Compensation: $25,013,348

    % Change: 2.5%

    Position on 2012 List: #2

  • #2. William C. Weldon

    Company: Johnson & Johnson

    Full title: Chairman of the Board until December 28, 2012; CEO until April 26, 2012

    2012 Compensation: $29,838,259

    2011 Compensation: $26,797,939

    % Change: 11.3%

    Position on 2012 List: #1

  • #1. Leonard S. Schleifer, M.D., Ph.D.

    Company: Regeneron

    Full title: President and CEO

    2012 Compensation: $30,047,0972

    2011 Compensation: $10,562,661

    % Change: 184.5%

    Position on 2012 List: Not ranked


Add a comment

  • You must be signed in to perform this action.
    Click here to Login or Register for free.
    You will be taken back to your selected item after Login/Registration.

Related content

Jobs

GEN Jobs powered by HireLifeScience.com connects you directly to employers in pharma, biotech, and the life sciences. View 40 to 50 fresh job postings daily or search for employment opportunities including those in R&D, clinical research, QA/QC, biomanufacturing, and regulatory affairs.
 Searching...
More »

GEN Poll

More » Poll Results »

New Drugs for Ebola

Do you think that biopharma companies should not have to go through the normal drug approval process in order to get potential life-saving therapies to Ebola patients more quickly?